Gene therapy development
AVROBIO develops gene therapies that use a patient’s own stem cells and modified genes to treat rare inherited diseases. The company focuses on creating and testing these treatments in clinical and preclinical programs.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
AVROBIO Inc. is a biotechnology company that develops gene therapies for rare inherited diseases. Its core idea is to take a patient’s own blood-forming stem cells, add a working copy of a faulty gene in the lab, and put the corrected cells back into the body. The goal is to treat the root cause of the disease rather than manage symptoms with lifelong medicines.
Because it is a drug developer, AVROBIO does not sell a broad catalog of products to everyday consumers. Its work is aimed at patients with serious single-gene disorders, and any future sales would likely flow through hospitals, specialty treatment centers, and healthcare payers after regulatory approval. Like many biotech companies at this stage, it has mainly depended on financing, research partnerships, and other drug-development funding rather than product sales.
What makes AVROBIO’s model different is the treatment style it is pursuing. Instead of making a drug that patients take repeatedly, it is trying to create one-time or infrequent gene therapies based on a patient’s own cells. That makes the science more complex and expensive than standard medicines, but it also gives the company a chance to target diseases where existing treatments are limited or only manage symptoms.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more